Analyst Consensus ?
ConsensusBuy77 ratings
Bullish6077.9%
Neutral1418.2%
Bearish33.9%
1 unmapped firm rating excluded from the percentages.
NVIDIA Corporation · NVDA · FY2027 Q1 · Calendar Q2 2026
NVIDIA Q1 FY2027: $82B Revenue, 85% YoY Growth, Vera CPU Launch
NVIDIA's Q1 FY2027 results reinforce the AI infrastructure supercycle thesis, with revenue of $81.6B beating consensus by 4.1% and EPS of $1.87 beating by 6.3%. Data-center revenue accelerated to 92% YoY growth, up from 75% in the prior quarter. The launch of the Vera CPU platform opens an estimated $200B TAM beyond GPUs, and a new reporting segmentation (Hyperscale vs. ACIE) provides investors with clearer workload visibility. Despite the beat, the stock declined 1.97% on the report with 4.95% subsequent drift, suggesting expectations were elevated. Q2 guidance of $91B implies continued sequential growth. Capital returns were boosted with an $80B share-repurchase authorization and a dividend increase to $0.20/share. At $196.51, the stock trades well below the analyst consensus target of $319.48, reflecting both the recent pullback and the wide dispersion in targets ($218 to $500).
Reported After market closeNASDAQTechnology
$5009.87B market cap
100quality score
Company context
Snapshot as of publicationNVIDIA Corporation stands as a prominent provider of advanced graphics, computational, and networking solutions, operating across the United States, Taiwan, China, and numerous international markets. Its Graphics division encompasses GeForce GPUs, central to PC gaming and personal computing experiences, along with the GeForce NOW cloud gaming service and its supporting infrastructure, as well as dedicated solutions for various gaming platforms. For professional visualization, it provides Quadro and NVIDIA RTX GPUs for enterprise workstations, further offering vGPU software designed for cloud-centric visual and virtual computing, automotive platforms for in-vehicle infotainment, and the Omniverse software suite, facilitating 3D design and virtual world creation. The Compute & Networking segment is a cornerstone for AI, high-performance computing (HPC), and accelerated data center platforms.…
Earnings scorecard
Reported versus consensus
Reported EPS
$1.87
Consensus $2
EPS surprise
+6.3%
Reported versus consensus
Reported revenue
$81.61B
Consensus $78.42B
Revenue surprise
+4.1%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$196.51Previous close
$13.3Low
$204.93Average
$500High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keybanc | Overweight | Overweight | Maintain | Jul 14, 2026 |
| Needham | Buy | Buy | Maintain | Jun 2, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jun 1, 2026 |
| Tigress Financial | Strong Buy | Strong Buy | Maintain | May 27, 2026 |
| Wedbush | Outperform | Outperform | Maintain | May 21, 2026 |
| UBS | Buy | Buy | Maintain | May 21, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 21, 2026 |
| Stifel | Buy | Buy | Maintain | May 21, 2026 |
| Rosenblatt | Buy | Buy | Maintain | May 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 21, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 21, 2026 |
| Jefferies | Buy | Buy | Maintain | May 21, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 21, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | May 21, 2026 |
| Benchmark | Buy | Buy | Maintain | May 21, 2026 |
| Baird | Outperform | Outperform | Maintain | May 21, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 21, 2026 |
| HSBC | Buy | Buy | Maintain | May 19, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 15, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 12, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Mar 19, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Feb 26, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 26, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Feb 26, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jan 9, 2026 |
| Susquehanna | Positive | Positive | Maintain | Nov 20, 2025 |
| Melius Research | Buy | Buy | Maintain | Nov 20, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Nov 20, 2025 |
| Barclays | Overweight | Overweight | Maintain | Nov 20, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 20, 2025 |
| Loop Capital | Buy | Buy | Maintain | Nov 3, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 3, 2025 |
| Craig-Hallum | Buy | Buy | Maintain | Aug 28, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 13, 2025 |
| DZ Bank | Buy | Buy | Maintain | Jul 15, 2025 |
| Phillip Securities | Accumulate | Buy | Maintain | Nov 22, 2024 |
| WestPark Capital | Buy | Buy | Maintain | Aug 29, 2024 |
| New Street Research | Buy | Neutral | Upgrade | Aug 6, 2024 |
| Wolfe Research | Outperform | Outperform | Maintain | May 23, 2024 |
| Edward Jones | Hold | Buy | Downgrade | Nov 22, 2023 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 22, 2023 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Aug 24, 2023 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Jun 30, 2023 |
| Erste Group | Buy | Hold | Upgrade | Apr 25, 2023 |
| Summit Insights Group | Buy | Hold | Upgrade | Nov 17, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | May 26, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 16, 2021 |
| Cascend | Buy | Buy | Maintain | Feb 24, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 22, 2020 |
| Nomura Instinet | Reduce | Reduce | Maintain | May 22, 2020 |
| Nomura | Reduce | Reduce | Maintain | May 22, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Dec 17, 2019 |
| New Street | Neutral | Buy | Downgrade | Nov 15, 2019 |
| Citi | Buy | Buy | Maintain | Nov 15, 2019 |
| Bank of America | Buy | Buy | Maintain | Nov 15, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | May 14, 2019 |
| Atlantic Equities | Overweight | Overweight | Maintain | Feb 22, 2019 |
| B. Riley Securities | Neutral | Buy | Downgrade | Nov 16, 2018 |
| B. Riley FBR | Neutral | Buy | Downgrade | Nov 16, 2018 |
| FBN Securities | Outperform | Outperform | Maintain | Jun 26, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Canaccord Genuity | Buy | Buy | Maintain | Nov 17, 2017 |
| Pacific Crest | Underweight | Upgrade | Jun 20, 2017 | |
| Macquarie | Neutral | Neutral | Maintain | Mar 31, 2017 |
| Roth Capital | Neutral | Buy | Downgrade | Feb 6, 2017 |
| MKM Partners | Buy | Buy | Maintain | Nov 22, 2016 |
| Topeka Capital | Buy | Hold | Upgrade | May 13, 2016 |
| Topeka | Buy | Hold | Upgrade | May 13, 2016 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | May 7, 2015 |
| ISI Group | Neutral | Neutral | Maintain | Apr 10, 2014 |
| CLSA | Underperform | Underperform | Maintain | Mar 21, 2014 |
| FBR Capital | Market Perform | Market Perform | Maintain | Feb 13, 2014 |
| Evercore Partners | Equal Weight | Underweight | Upgrade | Jan 21, 2014 |
| Brean Capital | Hold | Hold | Maintain | Sep 28, 2012 |
| Lazard | Neutral | Neutral | Maintain | Jun 28, 2012 |
| Salman Partners | Buy | Buy | Maintain | May 14, 2012 |
| Bank oferica | Neutral | Neutral | Maintain | Feb 16, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $196.51. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| KeyBanc | John Vinh | $330 | $203.53 | +67.9% | Jul 14, 2026 |
| Tigress Financial | Analyst unavailable | $425 | $210.24 | +116.3% | May 27, 2026 |
| Truist Financial | Analyst unavailable | $307 | $219.71 | +56.2% | May 21, 2026 |
| Wedbush | Analyst unavailable | $330 | $223.47 | +67.9% | May 21, 2026 |
| Argus Research | Jim Kelleher | $270 | $224.01 | +37.4% | May 21, 2026 |
| Goldman Sachs | Analyst unavailable | $285 | $223.47 | +45.0% | May 21, 2026 |
| UBS | Analyst unavailable | $280 | $223.47 | +42.5% | May 21, 2026 |
| Robert W. Baird | Analyst unavailable | $500 | $223.47 | +154.4% | May 21, 2026 |
| Evercore ISI | Mark Lipacis | $413 | $223.47 | +110.2% | May 21, 2026 |
| Needham | Rajvindra Gill | $270 | $223.47 | +37.4% | May 21, 2026 |
| Melius Research | Ben Reitzes | $400 | $223.47 | +103.6% | May 21, 2026 |
| KeyBanc | John Vinh | $310 | $223.47 | +57.8% | May 21, 2026 |
| RBC Capital | Analyst unavailable | $280 | $223.47 | +42.5% | May 21, 2026 |
| RBC Capital | Srini Pajjuri | $270 | $223.47 | +37.4% | May 21, 2026 |
| RBC Capital | Analyst unavailable | $315 | $223.47 | +60.3% | May 21, 2026 |
| Morgan Stanley | Joseph Moore | $288 | $223.47 | +46.6% | May 21, 2026 |
| Wolfe Research | Chris Caso | $275 | $223.47 | +39.9% | May 21, 2026 |
| Raymond James | Simon Leopold | $330 | $223.47 | +67.9% | May 21, 2026 |
| Mizuho Securities | Vijay Rakesh | $300 | $223.47 | +52.7% | May 21, 2026 |
| Stifel Nicolaus | Ruben Roy | $282 | $223.47 | +43.5% | May 21, 2026 |
| HSBC | Frank Lee | $325 | $222.32 | +65.4% | May 19, 2026 |
| Morgan Stanley | Joseph Moore | $285 | $225.32 | +45.0% | May 18, 2026 |
| KeyBanc | Analyst unavailable | $300 | $225.32 | +52.7% | May 18, 2026 |
| UBS | Analyst unavailable | $275 | $231.27 | +39.9% | May 14, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $350 | $225.83 | +78.1% | May 14, 2026 |
| Susquehanna | Christopher Rolland | $275 | $219.44 | +39.9% | May 12, 2026 |
| Wells Fargo | Analyst unavailable | $315 | $219.44 | +60.3% | May 12, 2026 |
| William Blair | Analyst unavailable | $300 | $184.43 | +52.7% | Mar 12, 2026 |
| Tigress Financial | Ivan Feinseth | $360 | $180.1 | +83.2% | Mar 5, 2026 |
| Wedbush | Matt Bryson | $300 | $179.72 | +52.7% | Mar 3, 2026 |
| Robert W. Baird | Tristan Gerra | $300 | $182.02 | +52.7% | Mar 2, 2026 |
| Morgan Stanley | Joseph Moore | $260 | $177.19 | +32.3% | Mar 2, 2026 |
| RBC Capital | Srini Pajjuri | $250 | $185.23 | +27.2% | Feb 26, 2026 |
| Fundamental Research | Analyst unavailable | $218 | $186.34 | +10.9% | Feb 26, 2026 |
| Goldman Sachs | James Schneider | $250 | $195.56 | +27.2% | Feb 25, 2026 |
| HSBC | Analyst unavailable | $310 | $191.55 | +57.8% | Feb 24, 2026 |
| UBS | Analyst unavailable | $400 | $191.16 | +103.6% | Feb 23, 2026 |
| UBS | Timothy Arcuri | $245 | $188.98 | +24.7% | Feb 11, 2026 |
| Jefferies | Blayne Curtis | $275 | $187.05 | +39.9% | Jan 16, 2026 |
| RBC Capital | Srini Pajjuri | $240 | $183.14 | +22.1% | Jan 14, 2026 |
| Mizuho Securities | Vijay Rakesh | $275 | $185.04 | +39.9% | Jan 9, 2026 |
| Stifel Nicolaus | Ruben Roy | $250 | $185.18 | +27.2% | Jan 8, 2026 |
| Truist Financial | Analyst unavailable | $275 | $174.14 | +39.9% | Dec 19, 2025 |
| Tigress Financial | Analyst unavailable | $350 | $174.89 | +78.1% | Dec 18, 2025 |
| Morgan Stanley | Analyst unavailable | $250 | $177.94 | +27.2% | Dec 1, 2025 |
| Seaport Global | Jay Goldberg | $140 | $176.51 | -28.8% | Dec 1, 2025 |
| Raymond James | Simon Leopold | $272 | $180.64 | +38.4% | Nov 20, 2025 |
| Jefferies | Analyst unavailable | $250 | $195.1 | +27.2% | Nov 20, 2025 |
| Robert W. Baird | Tristan Gerra | $275 | $186.52 | +39.9% | Nov 20, 2025 |
| Evercore ISI | Analyst unavailable | $352 | $184.62 | +79.1% | Nov 20, 2025 |
| Susquehanna | Analyst unavailable | $250 | $186.52 | +27.2% | Nov 20, 2025 |
| Morgan Stanley | Analyst unavailable | $235 | $186.52 | +19.6% | Nov 20, 2025 |
| Mizuho Securities | Analyst unavailable | $245 | $184.62 | +24.7% | Nov 20, 2025 |
| Bernstein | Analyst unavailable | $275 | $186.52 | +39.9% | Nov 20, 2025 |
| Barclays | Tom O'Malley | $275 | $194.17 | +39.9% | Nov 20, 2025 |
| KeyBanc | Analyst unavailable | $275 | $189.96 | +39.9% | Nov 20, 2025 |
| Deutsche Bank | Analyst unavailable | $215 | $186.52 | +9.4% | Nov 20, 2025 |
| Wells Fargo | Aaron Rakers | $265 | $186.52 | +34.9% | Nov 14, 2025 |
| Loop Capital Markets | Ananda Baruah | $350 | $202.49 | +78.1% | Nov 3, 2025 |
| Goldman Sachs | James Schneider | $240 | $202.89 | +22.1% | Oct 31, 2025 |
| New Street | Analyst unavailable | $307 | $202.43 | +56.2% | Oct 30, 2025 |
| Mizuho Securities | Vijay Rakesh | $235 | $210.61 | +19.6% | Oct 29, 2025 |
| UBS | Timothy Arcuri | $235 | $201.03 | +19.6% | Oct 29, 2025 |
| Melius Research | Ben Reitzes | $300 | $201.03 | +52.7% | Oct 29, 2025 |
| Evercore ISI | Mark Lipacis | $261 | $201.03 | +32.8% | Oct 29, 2025 |
| D.A. Davidson | Gil Luria | $250 | $201.03 | +27.2% | Oct 29, 2025 |
| Wolfe Research | Analyst unavailable | $230 | $201.03 | +17.0% | Oct 28, 2025 |
| UBS | Analyst unavailable | $320 | $180.03 | +62.8% | Oct 15, 2025 |
| HSBC | Frank Lee | $320 | $180.03 | +62.8% | Oct 15, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $189.11 | +52.7% | Oct 9, 2025 |
| Goldman Sachs | Analyst unavailable | $210 | $187.62 | +6.9% | Oct 6, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $240 | $188.88 | +22.1% | Oct 3, 2025 |
| Jefferies | Blayne Curtis | $220 | $180.92 | +12.0% | Sep 29, 2025 |
| Barclays | Tom O'Malley | $240 | $174.76 | +22.1% | Sep 25, 2025 |
| Evercore ISI | Mark Lipacis | $225 | $183.61 | +14.5% | Sep 23, 2025 |
| D.A. Davidson | Gil Luria | $210 | $183.61 | +6.9% | Sep 22, 2025 |
| Truist Financial | Analyst unavailable | $228 | $178.71 | +16.0% | Aug 28, 2025 |
| Needham | Analyst unavailable | $200 | $180.17 | +1.8% | Aug 28, 2025 |
| Morgan Stanley | Analyst unavailable | $210 | $180.17 | +6.9% | Aug 28, 2025 |
| Oppenheimer | Rick Schafer | $225 | $177.36 | +14.5% | Aug 28, 2025 |
| Robert W. Baird | Analyst unavailable | $225 | $179.81 | +14.5% | Aug 25, 2025 |
| Stifel Nicolaus | Analyst unavailable | $212 | $179.81 | +7.9% | Aug 25, 2025 |
| Evercore ISI | Mark Lipacis | $214 | $177.99 | +8.9% | Aug 22, 2025 |
| Piper Sandler | Harsh Kumar | $225 | $183.16 | +14.5% | Aug 13, 2025 |
| Morgan Stanley | Analyst unavailable | $200 | $179.27 | +1.8% | Jul 30, 2025 |
| Mizuho Securities | Vijay Rakesh | $192 | $170.7 | -2.3% | Jul 15, 2025 |
| Loop Capital Markets | Analyst unavailable | $250 | $154.31 | +27.2% | Jun 25, 2025 |
| Morgan Stanley | Joseph Moore | $170 | $131.29 | -13.5% | May 29, 2025 |
| Piper Sandler | Analyst unavailable | $180 | $139.19 | -8.4% | May 29, 2025 |
| Barclays | Tom O'Malley | $170 | $140.6 | -13.5% | May 29, 2025 |
| Piper Sandler | Harsh Kumar | $150 | $135.5 | -23.7% | May 27, 2025 |
| Raymond James | Srini Pajjuri | $150 | $104.49 | -23.7% | Apr 16, 2025 |
| Stifel Nicolaus | Ruben Roy | $180 | $117.9 | -8.4% | Mar 19, 2025 |
| HSBC | Frank Lee | $185 | $140.14 | -5.9% | Jan 13, 2025 |
| Oppenheimer | Rick Schafer | $175 | $140.14 | -10.9% | Jan 9, 2025 |
| Wolfe Research | Chris Caso | $180 | $146.67 | -8.4% | Nov 21, 2024 |
| Craig-Hallum | Richard Shannon | $175 | $146.67 | -10.9% | Nov 21, 2024 |
| Deutsche Bank | Ross Seymore | $140 | $104.75 | -28.8% | Nov 21, 2024 |
| Morgan Stanley | Joseph Moore | $168 | $104.75 | -14.5% | Nov 21, 2024 |
| Evercore ISI | Mark Lipacis | $190 | $104.75 | -3.3% | Nov 21, 2024 |
| Barclays | Tom O\'Malley | $160 | $104.75 | -18.6% | Nov 21, 2024 |
| Truist Financial | William Stein | $169 | $145.89 | -14.0% | Nov 21, 2024 |
| Robert W. Baird | Tristan Gerra | $195 | $145.89 | -0.8% | Nov 21, 2024 |
| Raymond James | Srini Pajjuri | $170 | $145.89 | -13.5% | Nov 21, 2024 |
| Mizuho Securities | Vijay Rakesh | $175 | $145.89 | -10.9% | Nov 21, 2024 |
| KeyBanc | John Vinh | $180 | $104.75 | -8.4% | Nov 19, 2024 |
| Evercore ISI | Mark Lipacis | $189 | $104.75 | -3.8% | Nov 18, 2024 |
| Jefferies | Blayne Curtis | $185 | $146.76 | -5.9% | Nov 15, 2024 |
| UBS | Timothy Arcuri | $185 | $145.26 | -5.9% | Nov 11, 2024 |
| Piper Sandler | Harsh Kumar | $175 | $139.59 | -10.9% | Nov 11, 2024 |
| Morgan Stanley | Joseph Moore | $160 | $139.59 | -18.6% | Nov 11, 2024 |
| Roth Capital | Suji Desilva | $200 | $139.34 | +1.8% | Oct 30, 2024 |
| Bank of America Securities | Vivek Arya | $190 | $136.93 | -3.3% | Oct 17, 2024 |
| Goldman Sachs | Toshiya Hari | $150 | $134.81 | -23.7% | Oct 11, 2024 |
| Bernstein | Stacy Rasgon | $155 | $116 | -21.1% | Sep 23, 2024 |
| Oppenheimer | Timothy Horan | $215 | $118.34 | +9.4% | Sep 19, 2024 |
| Bank of America Securities | Vivek Arya | $165 | $107.11 | -16.0% | Sep 5, 2024 |
| Wedbush | Matt Bryson | $138 | $119.37 | -29.8% | Aug 30, 2024 |
| Stifel Nicolaus | Ruben Roy | $165 | $120.77 | -16.0% | Aug 29, 2024 |
| Truist Financial | William Stein | $145 | $128.23 | -26.2% | Aug 27, 2024 |
| Morgan Stanley | Joseph Moore | $144 | $130.4 | -26.7% | Aug 26, 2024 |
| Citigroup | Atif Malik | $150 | $128.2 | -23.7% | Aug 23, 2024 |
| Wedbush | Dan Ives | $170 | $61.87 | -13.5% | Aug 22, 2024 |
| HSBC | Frank Lee | $145 | $128.25 | -26.2% | Aug 21, 2024 |
| Oppenheimer | Rick Schafer | $150 | $127.25 | -23.7% | Aug 20, 2024 |
| New Street | Pierre Ferragu | $120 | $106.62 | -38.9% | Aug 6, 2024 |
| Deutsche Bank | Ross Seymore | $100 | $100.93 | -49.1% | Aug 5, 2024 |
| RBC Capital | Brad Erickson | $107.5 | $51.87 | -45.3% | Jul 30, 2024 |
| Loop Capital Markets | Ananda Barush | $175 | $117.93 | -10.9% | Jul 22, 2024 |
| Piper Sandler | Harsh Kumar | $140 | $117.93 | -28.8% | Jul 22, 2024 |
| UBS | Timothy Arcuri | $150 | $125.83 | -23.7% | Jul 8, 2024 |
| Truist Financial | William Stein | $140 | $124.95 | -28.8% | Jun 27, 2024 |
| Goldman Sachs | Tito Labarta | $220 | $124.9 | +12.0% | Jun 26, 2024 |
| Jefferies | Blayne Curtis | $150 | $120.36 | -23.7% | Jun 24, 2024 |
| Melius Research | Ben Reitzes | $160 | $125.72 | -18.6% | Jun 21, 2024 |
| Rosenblatt Securities | Hans Mosesmann | $200 | $135.58 | +1.8% | Jun 18, 2024 |
| Argus Research | Jim Kelleher | $150 | $121.79 | -23.7% | Jun 11, 2024 |
| Goldman Sachs | Toshiya Hari | $135 | $121.03 | -31.3% | Jun 11, 2024 |
| Evercore ISI | Mark Lipacis | $131 | $122.19 | -33.3% | Jun 10, 2024 |
| Mizuho Securities | Vijay Rakesh | $127.5 | $115 | -35.1% | Jun 4, 2024 |
| Wells Fargo | Aaron Rakers | $125 | $109.63 | -36.4% | Jun 3, 2024 |
| Melius Research | Ben Reitzes | $125 | $106.47 | -36.4% | May 28, 2024 |
| Piper Sandler | Harsh Kumar | $120 | $103.81 | -38.9% | May 23, 2024 |
| Craig-Hallum | Richard Shannon | $125 | $104.87 | -36.4% | May 23, 2024 |
| Morgan Stanley | Joseph Moore | $116 | $94.95 | -41.0% | May 23, 2024 |
| Loop Capital Markets | Ananda Baruah | $120 | $94.95 | -38.9% | May 23, 2024 |
| Argus Research | Jim Kelleher | $110 | $102.93 | -44.0% | May 23, 2024 |
| Needham | Quinn Bolton | $120 | $94.95 | -38.9% | May 23, 2024 |
| Truist Financial | William Stein | $128.8 | $102.73 | -34.5% | May 23, 2024 |
| Stifel Nicolaus | Ruben Roy | $114 | $94.95 | -42.0% | May 23, 2024 |
| UBS | Timothy Arcuri | $120 | $94.95 | -38.9% | May 23, 2024 |
| Barclays | Tom O'Malley | $120 | $94.95 | -38.9% | May 23, 2024 |
| Wolfe Research | Chris Caso | $125 | $94.95 | -36.4% | May 23, 2024 |
| Mizuho Securities | Vijay Rakesh | $118 | $94.95 | -40.0% | May 23, 2024 |
| Deutsche Bank | Ross Seymore | $100 | $94.95 | -49.1% | May 23, 2024 |
| D.A. Davidson | Gil Luria | $90 | $94.95 | -54.2% | May 23, 2024 |
| Evercore ISI | Mark Lipacis | $131 | $94.95 | -33.3% | May 23, 2024 |
| KeyBanc | John Vinh | $130 | $102.75 | -33.8% | May 23, 2024 |
| Goldman Sachs | Toshiya Hari | $120 | $94.95 | -38.9% | May 23, 2024 |
| CFRA | Angelo Zino | $110 | $95.04 | -44.0% | May 21, 2024 |
| Morgan Stanley | Joe Moore | $100 | $94.98 | -49.1% | May 20, 2024 |
| Stifel Nicolaus | Ruben Roy | $108.5 | $92.48 | -44.8% | May 20, 2024 |
| Rosenblatt Securities | Hans Mosesmann | $140 | $92.48 | -28.8% | May 20, 2024 |
| Barclays | Tom O'Malley | $110 | $92.48 | -44.0% | May 20, 2024 |
| Robert W. Baird | Tristan Gerra | $120 | $92.48 | -38.9% | May 20, 2024 |
| Wells Fargo | Aaron Rakers | $115 | $91.36 | -41.5% | May 14, 2024 |
| Jefferies | Blayne Curtis | $120 | $90.2 | -38.9% | May 13, 2024 |
| HSBC | Frank Lee | $135 | $89.88 | -31.3% | May 10, 2024 |
| UBS | Timothy Arcuri | $115 | $87.76 | -41.5% | Apr 30, 2024 |
| Evercore ISI | Mark Lipacis | $116 | $86 | -41.0% | Apr 15, 2024 |
| KeyBanc | John Vinh | $120 | $87.15 | -38.9% | Apr 8, 2024 |
| UBS | Timothy Arcuri | $110 | $94.29 | -44.0% | Mar 22, 2024 |
| Mizuho Securities | Vijay Rakesh | $100 | $89.51 | -49.1% | Mar 20, 2024 |
| Oppenheimer | Rick Schafer | $110 | $90.37 | -44.0% | Mar 20, 2024 |
| Piper Sandler | Harsh Kumar | $105 | $90.37 | -46.6% | Mar 20, 2024 |
| Deutsche Bank | Ross Seymore | $85 | $90.37 | -56.7% | Mar 20, 2024 |
| Wedbush | Matt Bryson | $100 | $89.71 | -49.1% | Mar 19, 2024 |
| Goldman Sachs | Toshiya Hari | $100 | $89.38 | -49.1% | Mar 19, 2024 |
| CFRA | Angelo Zino | $100 | $89.4 | -49.1% | Mar 19, 2024 |
| Susquehanna | Christopher Rolland | $105 | $89.4 | -46.6% | Mar 19, 2024 |
| Wells Fargo | Aaron Rakers | $97 | $89.4 | -50.6% | Mar 19, 2024 |
| Truist Financial | William Stein | $117.7 | $88.46 | -40.1% | Mar 18, 2024 |
| HSBC | Frank Lee | $105 | $88.46 | -46.6% | Mar 18, 2024 |
| Needham | Quinn Bolton | $85 | $77.73 | -56.7% | Feb 22, 2024 |
| Truist Financial | William Stein | $69.1 | $66.99 | -64.8% | Feb 21, 2024 |
| Wedbush | Matt Bryson | $80 | $73.88 | -59.3% | Feb 16, 2024 |
| Susquehanna | Christopher Rolland | $85 | $73.82 | -56.7% | Feb 14, 2024 |
| Mizuho Securities | Vijay Rakesh | $92 | $72.25 | -53.2% | Feb 13, 2024 |
| Morgan Stanley | Joseph Moore | $75 | $69.51 | -61.8% | Feb 7, 2024 |
| Goldman Sachs | Toshiya Hari | $80 | $69.33 | -59.3% | Feb 5, 2024 |
| Wells Fargo | Aaron Rakers | $67.5 | $47.78 | -65.7% | Nov 27, 2023 |
| Goldman Sachs | Toshiya Hari | $62.5 | $49.13 | -68.2% | Nov 22, 2023 |
| Stifel Nicolaus | Ruben Roy | $60 | $49.52 | -69.5% | Nov 21, 2023 |
| KeyBanc | John Vinh | $65 | $50.08 | -66.9% | Nov 20, 2023 |
| Oppenheimer | Rick Schafer | $65 | $49.14 | -66.9% | Nov 16, 2023 |
| Bank of America Securities | Vivek Arya | $65 | $45.01 | -66.9% | Nov 6, 2023 |
| Loop Capital Markets | John Vinh | $65 | $42.1 | -66.9% | Oct 20, 2023 |
| Goldman Sachs | Steven Kron | $60.5 | $44.94 | -69.2% | Oct 2, 2023 |
| Craig-Hallum | Richard Shannon | $70 | $45.18 | -64.4% | Sep 12, 2023 |
| Morgan Stanley | Joseph Moore | $63 | $48.6 | -67.9% | Aug 24, 2023 |
| Loop Capital Markets | John Vinh | $62 | $43.3 | -68.4% | Aug 21, 2023 |
| Wedbush | Matt Bryson | $49 | $42.35 | -75.1% | Aug 18, 2023 |
| Rosenblatt Securities | Hans Mosesmann | $80 | $43.38 | -59.3% | Aug 17, 2023 |
| Truist Financial | William Stein | $54.5 | $47.22 | -72.3% | Jul 14, 2023 |
| Tigress Financial | Ivan Feinseth | $56 | $42.5 | -71.5% | Jul 7, 2023 |
| Morgan Stanley | Joseph Moore | $45 | $38.76 | -77.1% | May 25, 2023 |
| KeyBanc | John Vinh | $37.5 | $31.26 | -80.9% | May 22, 2023 |
| HSBC | Frank Lee | $35.5 | $27.79 | -81.9% | Apr 18, 2023 |
| Morgan Stanley | Joseph Moore | $30.4 | $25.54 | -84.5% | Mar 17, 2023 |
| Bernstein | Stacy Rasgon | $26.5 | $23.5 | -86.5% | Feb 27, 2023 |
| Jefferies | Mark Lipacis | $30 | $23.29 | -84.7% | Feb 27, 2023 |
| Loop Capital Markets | John Vinh | $28 | $23.42 | -85.8% | Feb 23, 2023 |
| Raymond James | Simon Leopold | $37 | $20.75 | -81.2% | Feb 23, 2023 |
| Morgan Stanley | Joseph Moore | $24.6 | $20.66 | -87.5% | Feb 22, 2023 |
| KeyBanc | John Vinh | $28 | $21.17 | -85.8% | Feb 17, 2023 |
| HSBC | Frank Lee | $13.6 | $15.65 | -93.1% | Jan 10, 2023 |
| Needham | Needham Needham | $23 | $16.17 | -88.3% | Dec 20, 2022 |
| Cowen & Co. | Cowen Cowen | $22 | $16.57 | -88.8% | Dec 18, 2022 |
| Tigress Financial | Analyst unavailable | $25 | $17.17 | -87.3% | Dec 9, 2022 |
| Wedbush | Analyst unavailable | $17.5 | $16.2 | -91.1% | Nov 17, 2022 |
| Morgan Stanley | Analyst unavailable | $17.5 | $15.91 | -91.1% | Nov 17, 2022 |
| Susquehanna | Analyst unavailable | $18.5 | $15.91 | -90.6% | Nov 17, 2022 |
| Deutsche Bank | Analyst unavailable | $15 | $15.91 | -92.4% | Nov 17, 2022 |
| Barclays | Blayne Curtis | $14 | $13.22 | -92.9% | Nov 3, 2022 |
| Barclays | Blayne Curtis | $19 | $13.78 | -90.3% | Sep 21, 2022 |
| Oppenheimer | Rick Schafer | $12.5 | $6.59 | -93.6% | Sep 20, 2022 |
| Mizuho Securities | Vijay Rakesh | $20.5 | $12.93 | -89.6% | Sep 15, 2022 |
| Mizuho Securities | Vijay Rakesh | $12.5 | $12.88 | -93.6% | Sep 15, 2022 |
| Mizuho Securities | Vijay Rakesh | $22.5 | $14.38 | -88.6% | Sep 9, 2022 |
| Daiwa | Louis Miscioscia | $13.3 | $13.94 | -93.2% | Sep 2, 2022 |
| Rosenblatt Securities | Hans Mosesmann | $32 | $17.64 | -83.7% | Aug 25, 2022 |
| Piper Sandler | Harsh Kumar | $23.5 | $17.22 | -88.0% | Aug 25, 2022 |
| Raymond James | Melissa Fairbanks | $21 | $17.22 | -89.3% | Aug 25, 2022 |
| Raymond James | Melissa Fairbanks | $21 | $17.22 | -89.3% | Aug 25, 2022 |
| Goldman Sachs | Toshiya Hari | $16.2 | $17.22 | -91.8% | Aug 25, 2022 |
| Robert W. Baird | Tristan Gerra | $13.5 | $17.22 | -93.1% | Aug 25, 2022 |
| Credit Suisse | Randy Abrams | $20.5 | $17.22 | -89.6% | Aug 25, 2022 |
| Wedbush | Matt Bryson | $16 | $17.22 | -91.9% | Aug 25, 2022 |
| Benchmark Co. | Cody Acree | $21.5 | $17.22 | -89.1% | Aug 25, 2022 |
| Needham | Rajvindra Gill | $18.5 | $17.22 | -90.6% | Aug 25, 2022 |
| KeyBanc | John Vinh | $23 | $17.22 | -88.3% | Aug 25, 2022 |
| BMO Capital | Ambrish Srivastava | $23 | $17.22 | -88.3% | Aug 25, 2022 |
| KeyBanc | John Vinh | $23 | $17.11 | -88.3% | Aug 22, 2022 |
| Barclays | Blayne Curtis | $20 | $17.09 | -89.8% | Aug 9, 2022 |
| Deutsche Bank | Ross Seymore | $17.5 | $18.16 | -91.1% | Jul 30, 2022 |
| Goldman Sachs | Toshiya Hari | $16.6 | $17.38 | -91.6% | Jul 27, 2022 |
| Robert W. Baird | Tristan Gerra | $15 | $17.02 | -92.4% | Jul 26, 2022 |
| Tigress Financial | Ivan Feinseth | $15.5 | $7.94 | -92.1% | Jul 8, 2022 |
| Cowen & Co. | Matthew Ramsay | $26.5 | $17.11 | -86.5% | May 26, 2022 |
| BMO Capital | Ambrish Srivastava | $30 | $17.85 | -84.7% | May 26, 2022 |
| FBN Securities | Shebly Seyrafi | $25 | $17.85 | -87.3% | May 26, 2022 |
| KeyBanc | John Vinh | $25 | $17.85 | -87.3% | May 26, 2022 |
| Westpark Capital | Ruben Roy | $24 | $17.85 | -87.8% | May 26, 2022 |
| Robert W. Baird | Tristan Gerra | $16.5 | $17.85 | -91.6% | May 26, 2022 |
| Morgan Stanley | Joseph Moore | $18.2 | $17.85 | -90.7% | May 26, 2022 |
| Evercore ISI | C J Muse | $30 | $17.85 | -84.7% | May 26, 2022 |
| Needham | Rajvindra Gill | $24 | $17.85 | -87.8% | May 26, 2022 |
| Oppenheimer | Rick Schafer | $15 | $8.35 | -92.4% | May 23, 2022 |
| Wells Fargo | Aaron Rakers | $25 | $16.69 | -87.3% | May 22, 2022 |
| Susquehanna | Christopher Rolland | $28 | $17.12 | -85.8% | May 20, 2022 |
| Bank of America Securities | Vivek Arya | $16 | $8.35 | -91.9% | May 20, 2022 |
| Morgan Stanley | Joseph Moore | $21.7 | $19.6 | -89.0% | May 3, 2022 |
| Barclays | Blayne Curtis | $29.5 | $19.78 | -85.0% | Apr 28, 2022 |
| Deutsche Bank | Ross Seymore | $25.5 | $19.33 | -87.0% | Apr 25, 2022 |
| New Street | Pierre Ferragu | $28 | $21.26 | -85.8% | Apr 15, 2022 |
| New Street | Pierre Ferragu | $27 | $22.2 | -86.3% | Apr 13, 2022 |
| Truist Financial | William Stein | $29.8 | $21.92 | -84.8% | Apr 11, 2022 |
| Tigress Financial | Ivan Feinseth | $41 | $26.71 | -79.1% | Apr 3, 2022 |
| Bernstein | Stacy Rasgon | $35 | $25.63 | -82.2% | Mar 23, 2022 |
| Rosenblatt Securities | Hans Mosesmann | $40 | $26.52 | -79.6% | Mar 22, 2022 |
| Mizuho Securities | Vijay Rakesh | $34.5 | $26.52 | -82.4% | Mar 22, 2022 |
| Bank of America Securities | Vivek Arya | $37.5 | $26.73 | -80.9% | Mar 21, 2022 |
| BMO Capital | Ambrish Srivastava | $37.5 | $26.73 | -80.9% | Mar 21, 2022 |
| Wells Fargo | Christopher Harvey | $37 | $26.45 | -81.2% | Mar 20, 2022 |
| Credit Suisse | John Pitzer | $40 | $26.45 | -79.6% | Mar 18, 2022 |
| Deutsche Bank | Ross Seymore | $28.5 | $24.5 | -85.5% | Mar 16, 2022 |
| Cowen & Co. | Matt Ramsay | $35 | $22.97 | -82.2% | Mar 15, 2022 |
| Goldman Sachs | Toshiya Hari | $24.5 | $21.35 | -87.5% | Mar 7, 2022 |
| Needham | Rajvindra Gill | $40 | $24.5 | -79.6% | Feb 17, 2022 |
| Piper Sandler | Harsh Kumar | $35 | $26.49 | -82.2% | Feb 15, 2022 |
| New Street | Pierre Ferragu | $25 | $24.32 | -87.3% | Feb 4, 2022 |
| UBS | Timothy Arcuri | $35 | $24.15 | -82.2% | Jan 20, 2022 |
| Truist Financial | William Stein | $35 | $28.18 | -82.2% | Jan 6, 2022 |
| Evercore ISI | C J Muse | $37.5 | $27.6 | -80.9% | Jan 5, 2022 |
| Benchmark Co. | David Williams | $36.5 | $31.67 | -81.4% | Nov 18, 2021 |
| Oppenheimer | Rick Schafer | $35 | $31.67 | -82.2% | Nov 18, 2021 |
| Argus Research | Jim Kelleher | $23 | $19.55 | -88.3% | Jul 23, 2021 |
| Westpark Capital | Ruben Roy | $19.13 | $17.35 | -90.3% | Jun 9, 2021 |
| FBN Securities | Shebly Seyrafi | $18.75 | $15.48 | -90.5% | May 27, 2021 |
Track every rating change on NVDA the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-1.8%
Event window
SPY move
+0.2%
Same window
Abnormal move
-2.0%
Stock minus SPY
Volume
1.3×
Versus trailing sessions
Subsequent drift
-4.9%
Up to 20 sessions
NVDASPY benchmark
Follow NVDA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue stepped up from $68B in Q4 FY2026 to $82B in Q1 FY2027, with data-center growth accelerating from 75% to 92% YoY. NVIDIA introduced a new Hyperscale vs. ACIE reporting segmentation. The Vera CPU family was launched, targeting a $200B TAM. A new $80B share-repurchase authorization was announced alongside a dividend increase to $0.20/share, with $20B already returned in Q1. VeraRubin production was moved to Q3 2026 (previously H2 FY2026). Q2 guidance of $91B implies further sequential acceleration. China data-center revenue remains excluded from the outlook.
Guidance delta
Guidance sentiment was maintained. Q2 FY2027 revenue was guided to $91B, up from $82B reported in Q1. The prior quarter had set Q1 guidance at approximately $78B, which was exceeded by $4B. Capex outlook remains increasing. Management reaffirmed its target of $1 trillion in cumulative Blackwell/Rubin revenue from 2025 through 2027. China revenue remains excluded from the forward outlook due to export-license uncertainty.
Key takeaways
- Record $82B revenue beat estimates by 4.1%; EPS of $1.87 beat by 6.3%.
- Data-center revenue grew 92% YoY, accelerating from 75% in the prior quarter.
- New Hyperscale vs. ACIE reporting segmentation improves workload visibility.
- Vera CPU launch opens an estimated $200B TAM beyond GPUs.
- $80B buyback authorization and dividend increase to $0.20/share signal strong capital returns.
- Q2 guidance of $91B implies continued sequential acceleration.
Management priorities
- Begin VeraRubin production shipments in Q3 2026 with ramp through Q4.
- Target $1 trillion in cumulative Blackwell/Rubin revenue from 2025 through 2027.
- Expand partnerships across hyperscalers, AI-native clouds, and enterprise customers.
- Maintain aggressive share repurchases and dividend growth.
- Invest in R&D and ecosystem expansion for agentic AI and physical AI markets.
Related earnings events
TechnologyINTC · FY2026 Q2 · Calendar Q3 2026Intel Beats on AI Strength, but Foundry Losses and Rising Capex Drag SharesMU · FY2026 Q3 · Calendar Q2 2026Micron Crushes Q3 on AI Memory Demand, Guides to $50B Q4 With 86% MarginsAVGO · FY2026 Q2 · Calendar Q2 2026Broadcom Q2 FY26: AI Chip Revenue Hits $10.8B but Stock Sinks 13%
Sources
- Earnings call transcript and parsed analysis · 2026-05-21T01:22:24.244905+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-28T00:11:19.031040+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T00:11:19.028206+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.